distant memory as in the climb in sales and beneficial patient outcomes will be exponentially irreversible...
what that will mean for the sp here is clear...in my opinion
generated revenue, clinically validated product on the shelves and being prescribed, more in trials nearing completion, expansion into overseas markets complementing the supply and demand which is also exponentially increasing as markets ...both within the US and in countries around the globe transition to a revenue positive model whilst easing the opioid prescription dependency killing patients.....its a no brainer! ...just to highlight but a few points..... IMO
GLTASAH
- Forums
- ASX - By Stock
- Zelira AAN(s) overtime, road to revenue $
distant memory as in the climb in sales and beneficial patient...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ZLD (ASX) to my watchlist
(20min delay)
|
|||||
Last
70.0¢ |
Change
-0.030(4.11%) |
Mkt cap ! $7.943M |
Open | High | Low | Value | Volume |
73.0¢ | 73.0¢ | 70.0¢ | $1.785K | 2.485K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2160 | 70.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
76.0¢ | 733 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2160 | 0.700 |
2 | 16175 | 0.680 |
1 | 1000 | 0.670 |
1 | 5000 | 0.600 |
1 | 1686 | 0.590 |
Price($) | Vol. | No. |
---|---|---|
0.760 | 733 | 1 |
0.770 | 474 | 1 |
0.800 | 710 | 1 |
0.810 | 1045 | 2 |
0.860 | 362 | 3 |
Last trade - 14.24pm 29/03/2024 (20 minute delay) ? |
Featured News
ZLD (ASX) Chart |